{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T22:05:54Z","timestamp":1772229954296,"version":"3.50.1"},"reference-count":71,"publisher":"Oxford University Press (OUP)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12,1]]},"DOI":"10.1093\/ndt\/gfx041","type":"journal-article","created":{"date-parts":[[2017,2,20]],"date-time":"2017-02-20T12:12:05Z","timestamp":1487592725000},"page":"1967-1976","source":"Crossref","is-referenced-by-count":16,"title":["The quest for equilibrium: exploring the thin red line between bleeding and ischaemic risks in the management of acute coronary syndromes in chronic kidney disease patients"],"prefix":"10.1093","volume":"32","author":[{"given":"Alexandru","family":"Burlacu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simonetta","family":"Genovesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Kanbay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Rossignol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maciej","family":"Banach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolanta","family":"Ma\u0142yszko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Goldsmith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Covic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,3,27]]},"reference":[{"key":"key\n\t\t\t\t20171201225837_gfx041-B1","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/CIRCULATIONAHA.109.865352","article-title":"Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry","volume":"121","year":"2010","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B2","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/heart.89.9.1003","article-title":"Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE)","volume":"89","year":"2003","journal-title":"Heart"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B3","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","article-title":"ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"33","year":"2012","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2796.2009.02204.x","article-title":"Relation between renal function, presentation, use of therapies and in-hospital complications in acute coronary syndrome: data from the SWEDEHEART register","volume":"268","year":"2010","journal-title":"J Intern Med"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/ejhf.11","article-title":"The impact of kidney function on outcomes following high risk myocardial infarction: findings from 27 610 patients","volume":"16","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B6","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1161\/CIRCULATIONAHA.111.028282","article-title":"Determinants and consequences of renal function variations with aldosterone blocker therapy in heart failure patients after myocardial infarction: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study","volume":"125","year":"2012","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B7","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/CIR.0000000000000183","article-title":"Pharmacotherapy in chronic kidney disease patients presenting with acute coronary syndrome: a scientific statement from the American Heart Association","volume":"131","year":"2015","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","article-title":"2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)","volume":"37","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B9","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","article-title":"2014 ESC\/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)","volume":"35","year":"2014","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B10","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1161\/CIRCULATIONAHA.108.838169","article-title":"Influence of renal function on the effects of early revascularization in non-ST-elevation myocardial infarction: data from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART)","volume":"120","year":"2009","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B11","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1097\/01.ASN.0000083900.92829.F5","article-title":"Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease","volume":"14","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B12","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1161\/CIRCULATIONAHA.111.084996","article-title":"Antithrombotic therapy in patients with chronic kidney disease","volume":"125","year":"2012","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B13","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1053\/j.ajkd.2005.07.043","article-title":"Outcomes of acute coronary syndrome in a large Canadian cohort: impact of chronic renal insufficiency, cardiac interventions, and anemia","volume":"46","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B14","first-page":"1799","article-title":"Incident acute coronary syndromes in chronic dialysis patients in the United States","volume":"62","year":"2002","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1160\/TH10-12-0785","article-title":"Haemostatic profiles assessed by thromboelastography in patients with end-stage renal disease","volume":"106","year":"2011","journal-title":"Thromb Haemostasis"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B16","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1161\/CIR.0000000000000156","article-title":"2014 ACC\/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards)","volume":"132","year":"2015","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B17","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1373\/clinchem.2015.251835","article-title":"Prognostic value of serial changes in high-sensitivity cardiac troponin I and T over 3 months using reference change values in hemodialysis patients","volume":"62","year":"2016","journal-title":"Clin Chem"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B18","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.clinbiochem.2016.05.015","article-title":"Monthly reference change value of cardiac troponin in hemodialysis patients as a useful tool for long-term cardiovascular management","volume":"49","year":"2016","journal-title":"Clin Biochem"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B19","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0140-6736(14)60384-6","article-title":"Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure","volume":"383","year":"2014","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B20","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1681\/ASN.2015050535","article-title":"The risk of major hemorrhage with CKD","volume":"27","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B21","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/ckj\/sfu080","article-title":"Anticoagulation in chronic kidney disease patients-the practical aspects","volume":"7","year":"2014","journal-title":"Clin Kidney J"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B22","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1378\/chest.15-1719","article-title":"Stroke, major bleeding, and mortality outcomes in warfarin users with atrial fibrillation and chronic kidney disease: a meta-analysis of observational studies","volume":"149","year":"2016","journal-title":"Chest"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B23","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.amjmed.2016.08.019","article-title":"Creatinine clearance is not equal to glomerular filtration rate and Cockcroft-Gault equation is not equal to Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation","volume":"129","year":"2016","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B24","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1016\/j.jacc.2015.04.037","article-title":"Choice of estimated glomerular filtration rate equation impacts drug-dosing recommendations and risk stratification in patients with chronic kidney disease undergoing percutaneous coronary interventions","volume":"65","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B25","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s11239-015-1255-x","article-title":"Influence of chronic kidney disease on anticoagulation levels and bleeding after primary percutaneous coronary intervention in patients treated with unfractionated heparin","volume":"41","year":"2016","journal-title":"J Thromb Thrombolys"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/jamainternmed.2015.6102","article-title":"Representation of patients with kidney disease in trials of cardiovascular interventions: an updated systematic review","volume":"176","year":"2016","journal-title":"JAMA Intern Med"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B27","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1161\/CIRCULATIONAHA.114.014113","article-title":"Dabigatran and rivaroxaban use in atrial fibrillation patients on hemodialysis","volume":"131","year":"2015","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B28","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.jacc.2004.06.072","article-title":"The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease","volume":"44","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B29","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ahj.2011.12.002","article-title":"Renal failure and acute myocardial infarction: clinical characteristics in patients with advanced chronic kidney disease, on dialysis, and without chronic kidney disease. A collaborative project of the United States Renal Data System\/National Institutes of Health and the National Registry of Myocardial Infarction","volume":"163","year":"2012","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B30","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1161\/CIRCULATIONAHA.107.696765","article-title":"Clinical characteristics of dialysis patients with acute myocardial infarction in the United States: a collaborative project of the United States Renal Data System and the National Registry of Myocardial Infarction","volume":"116","year":"2007","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B31","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(12)60572-8","article-title":"Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study","volume":"380","year":"2012","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B32","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1053\/j.ajkd.2005.11.017","article-title":"Differential symptoms of acute myocardial infarction in patients with kidney disease: a community-wide perspective","volume":"47","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B33","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.amjmed.2011.10.031","article-title":"Determinants of high-sensitivity troponin T among patients with a noncardiac cause of chest pain","volume":"125","year":"2012","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B34","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1161\/CIRCULATIONAHA.114.014245","article-title":"Optimal cutoff levels of more sensitive cardiac troponin assays for the early diagnosis of myocardial infarction in patients with renal dysfunction","volume":"131","year":"2015","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B35","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1161\/CIRCULATIONAHA.108.828541","article-title":"Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can rapid risk stratification of unstable angina patients suppress adverse outcomes with early implementation of the ACC\/AHA Guidelines) bleeding score","volume":"119","year":"2009","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B36","first-page":"1431","article-title":"Role of the CHADS2 score in acute coronary syndromes: risk of subsequent death or stroke in patients with and without atrial fibrillation","volume":"141","year":"2012","journal-title":"Chest"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B37","first-page":"545","article-title":"CHA2DS2-VASc and R2CHA2DS2-VASc scores have predictive value in patients with acute coronary syndromes","volume":"125","year":"2015","journal-title":"Polskie Archiwum Medycyny Wewnetrznej"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B38","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/heartjnl-2014-306962","article-title":"Contrast-induced nephropathy following angiography and cardiac interventions","volume":"102","year":"2016","journal-title":"Heart"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B39","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s11886-012-0284-8","article-title":"Is there attenuation of benefit of invasive therapy in patients with chronic kidney disease? Results from randomized trials and registry data","volume":"14","year":"2012","journal-title":"Curr Cardiol Rep"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B40","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0002-9343(97)00150-2","article-title":"Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality","volume":"103","year":"1997","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B41","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/eurheartj\/ehp014","article-title":"Temporal management patterns and outcomes of non-ST elevation acute coronary syndromes in patients with kidney dysfunction","volume":"30","year":"2009","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B42","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1097\/01.ASN.0000135969.33773.0B","article-title":"\u201cRenalism\u201d: inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency","volume":"15","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B43","first-page":"132","article-title":"Contemporary management of coronary artery disease and acute coronary syndrome in patients with chronic kidney disease and end-stage renal disease","volume":"29","year":"2013","journal-title":"Acta Cardiol Sin"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B44","doi-asserted-by":"crossref","first-page":"e0153478","DOI":"10.1371\/journal.pone.0153478","article-title":"Impact of an early invasive strategy versus conservative strategy for unstable angina and non-ST elevation acute coronary syndrome in patients with chronic kidney disease: a systematic review","volume":"11","year":"2016","journal-title":"PloS One"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B45","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.2215\/CJN.05551008","article-title":"Early angiography in patients with chronic kidney disease: a collaborative systematic review","volume":"4","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B46","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1056\/NEJMoa044259","article-title":"Early invasive versus selectively invasive management for acute coronary syndromes","volume":"353","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B47","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/CIRCULATIONAHA.109.933796","article-title":"Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial","volume":"122","year":"2010","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B48","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B49","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","year":"2011","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B50","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","year":"2011","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B51","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","year":"2013","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B52","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/CIRCULATIONAHA.113.003628","article-title":"Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) trial analysis","volume":"129","year":"2014","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B53","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1093\/eurheartj\/ehr342","article-title":"Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment","volume":"32","year":"2011","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B54","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/jamacardio.2016.1170","article-title":"Efficacy and Safety of apixaban compared with warfarin in patients with atrial fibrillation in relation to renal function over time: insights from the ARISTOTLE randomized clinical trial","volume":"1","year":"2016","journal-title":"JAMA Cardiol"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B55","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/CIRCULATIONAHA.116.022361","article-title":"Impact of renal function on outcomes with edoxaban in the ENGAGE AF-TIMI 48 trial","volume":"134","year":"2016","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B56","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.amjcard.2015.09.046","article-title":"Meta-analysis of renal function on the safety and efficacy of novel oral anticoagulants for atrial fibrillation","volume":"117","year":"2016","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B57","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/europace\/euw295","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS: the Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC endorsed by the European Stroke Organisation (ESO)","volume":"18","year":"2016","journal-title":"Europace"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B58","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/jcph.628","article-title":"Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end-stage renal disease on hemodialysis","volume":"56","year":"2016","journal-title":"J Clin Pharmacol"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B59","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/jcph.633","article-title":"Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixaban","volume":"56","year":"2016","journal-title":"J Clin Pharmacol"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B60","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/j.ajkd.2015.01.022","article-title":"Dose-finding study of rivaroxaban in hemodialysis patients","volume":"66","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B61","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/S0140-6736(00)02324-2","article-title":"Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B62","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa1112277","article-title":"Rivaroxaban in patients with a recent acute coronary syndrome","volume":"366","year":"2012","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B63","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0140-6736(03)14287-0","article-title":"Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial","volume":"362","year":"2003","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B64","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1105819","article-title":"Apixaban with antiplatelet therapy after acute coronary syndrome","volume":"365","year":"2011","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B65","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1093\/eurheartj\/ehr113","article-title":"Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial","volume":"32","year":"2011","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B66","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1093\/eurheartj\/eht049","article-title":"New oral anticoagulants in addition to single or dual antiplatelet therapy after an acute coronary syndrome: a systematic review and meta-analysis","volume":"34","year":"2013","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B67","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1160\/TH13-08-0677","article-title":"Antithrombotic therapy in atrial fibrillation and stent implantation: treatment or threats by the use of triple or dual antithrombotic therapy","volume":"110","year":"2013","journal-title":"Thromb Haemostasis"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B68","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1093\/eurheartj\/ehu298","article-title":"Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and\/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS)","volume":"35","year":"2014","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B69","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1161\/CIRCULATIONAHA.112.115386","article-title":"Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial","volume":"127","year":"2013","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B70","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1056\/NEJMoa1611594","article-title":"Prevention of bleeding in patients with atrial fibrillation undergoing PCI","volume":"375","year":"2016","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171201225837_gfx041-B71","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/jama.296.11.1377","article-title":"Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease","volume":"296","year":"2006","journal-title":"JAMA"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/32\/12\/1967\/22144369\/gfx041.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T15:33:20Z","timestamp":1719070400000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/ndt\/article\/32\/12\/1967\/3091492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,27]]},"references-count":71,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,3,27]]},"published-print":{"date-parts":[[2017,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfx041","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,12]]},"published":{"date-parts":[[2017,3,27]]}}}